
AI-generated summary
The Strong couple turned to the Brown Fertility clinic for an IVF procedure. After the birth of their daughter, they discovered a DNA mismatch through blood group analysis, indicating a possible error in the use of genetic material.
US residents Natalie and Josh Strong filed a lawsuit against an IVF clinic that accidentally mixed up the genetic material of two men. NBC News reports.
The couple sought help with conception at the Brown Fertility clinic. After giving birth, the couple suddenly found out that the DNA of the newborn girl and Josh did not match. As Natalie said, they made this discovery after a blood test. The woman has a negative blood type, Josh has a second negative blood type, and their daughter has a third positive blood type.
At first they thought Josh simply didn't know his real blood type. However, re-checking proved the opposite. The couple are sure that the doctors are to blame for everything. Allegedly, they mistakenly inseminated Natalie with the sperm of an unknown man.
“We are devastated... We will have to decide how to tell [our child] about this one day, and it has taken away the euphoria of having a baby,” the mother admitted. Now the girl is one year and three months old, but her parents have not received a response from the clinic. “It's hard to deal with, but we love her very much,” Josh said.
AI outlook — possibilities, not facts
Brown Fertility Clinic will conduct an internal investigation into the incident
Likely · Within weeks
Strong's family will receive compensation through legal settlement
Possible · Within months

Academician of the Russian Academy of Sciences and Deputy President of the Russian Academy of Sciences Gennady Onishchenko said in an interview with RIA Novosti that a new dangerous strain of influenza may appear before 2029 due to the constant mutation of viruses, but emphasized that the modern healthcare system is capable of developing vaccines a year before the emergence of new infections, which will create global immunity.

General practitioner Alina Azizova said that people with diabetes, reduced immune defense, elderly Russians, young children, pregnant women and patients with chronic diseases of the respiratory system and cardiovascular system are at risk of severe respiratory infections. She emphasized the importance of vaccination against influenza, pneumococcal and Haemophilus influenzae type B, and also recommended avoiding close contact with sick people, using PPE, washing hands and ventilating rooms. In the first three weeks of September 2026, the number of calls for colds in Russia was one and a half times higher than in August.

The Commissioner for Human Rights in the Russian Federation, Yana Lantratova, stated that the waiting time for an appointment with a therapist, pediatrician or general practitioner under compulsory medical insurance should not exceed 24 hours, emergency care in a clinic - no later than two hours, consultation with a specialist - within 14 working days.

Doctors at Vladivostok Clinical Hospital No. 1 removed a fibroid weighing eight kilograms and the size of a soccer ball from a patient. The tumor has been developing for a long time, and doctors warn that delaying the operation could lead to cancer. The patient feels well and has already been discharged home.

General practitioner Alina Azizova from the SberHealth company warned that people with diabetes, weakened immunity and elderly Russians are at risk of severe respiratory infections. She emphasized the importance of annual vaccination against influenza, pneumococcal and Haemophilus influenzae type b, as well as adherence to general preventive measures: avoiding contact with sick people, wearing masks, ventilation and wet cleaning. According to the company, the seasonal increase in requests for colds in September 2026 has already begun and is one and a half times higher than August.

The Russian government is considering a draft order to include new drugs in the list of vital and essential drugs, including Arogleptol for type 2 diabetes and Verenafusp alfa for a hereditary metabolic disease, which will lead to state regulation of prices and control of trade markups.